Table 3.
Dose response to intervention in primary and secondary outcomes at 5-year follow-up.
|
Mean difference (<50%/<6 calls)b (n=26) | Mean difference (≥50%/≥6 calls)b (n=54) | |||
β (95% CI) | P value | β (95% CI) | P value | ||
Primary outcomes | |||||
|
Systolic blood pressure | 0.42 (–5.89 to 6.72) | .90 | –4.05 (–10.11 to 2.02) | .19 |
|
Diastolic blood pressure | 7.13 (2.31 to 11.95) | .004 | 1.48 (–2.84 to 5.79) | .50 |
Secondary outcomes | |||||
|
Body weight (kg) | –3.57 (–10.47 to 3.34) | .31 | –6.23 (–11.47 to –0.99) | .02 |
|
BMI (kg/m2) | –1.79 (–4.45 to 0.87) | .19 | –2.81 (-4.77; -0.85) | .005 |
|
Physical activity (METsa/min per week) | –163.55 (–915.48 to 588.38) | .67 | 59.37 (–703.91 to 822.64) | .88 |
|
Daily intake of fruits and vegetablesb | 0.25 (–0.39 to 0.89) | .45 | –0.04 (–0.56; 0.49) | .89 |
|
Daily intake of high-sodium foodb | –0.05 (–0.47 to 0.37) | .82 | –0.28 (–0.62; 0.06) | .11 |
|
Daily intake of high-fat and high-sugar foodsb | 1.74 (0.65 to 2.83) | .002 | 0.64 (–0.20; 1.49) | .14 |
aMETs: metabolic equivalents.
bMean differences were estimated using linear mixed models using information from the baseline, 6-month, 12-month, and 5-year follow-ups and were controlled by sex and age.